Menopause and Sexual Health in Older Adults: A Clinical Framework for Geriatric Care
A geriatric review links falling estrogen and testosterone to sexual dysfunction in older women and men and offers a framework for evaluating and managing it.
Summary
Sexual health is part of well-being in later life, yet clinicians often overlook it. This review describes menopause as a whole-body hormonal transition driven by estrogen deficiency. That deficiency produces hot flashes, bone and muscle changes, and genitourinary problems in older women. Falling estrogen and testosterone help explain vaginal dryness, painful intercourse, and reduced libido. Other health conditions, multiple medications, and physical limitations can make these problems worse. In men, a gradual decline in testosterone may reduce libido and erectile function. The authors offer a clinically focused framework for evaluating and managing sexual dysfunction in geriatric practice. This is a narrative review, and only the abstract was available, so the specific treatments, evidence grades, and recommendations are not covered here. The review is most useful as a prompt for clinicians to ask about sexual function routinely and consider hormonal and non-hormonal contributors.
Detailed Summary
Sexual health is a core part of well-being as people age, but it is still underrecognized in clinical practice. This review from Florida International University addresses that gap for geriatric care, covering both older women and older men.
The authors describe menopause as a systemic endocrine transition defined by estrogen deficiency. In plain terms, losing estrogen affects far more than reproduction. It drives a cascade of vasomotor symptoms such as hot flashes, musculoskeletal changes, and genitourinary problems. Declining estrogen and testosterone together contribute to vaginal dryness, painful intercourse (dyspareunia), and decreased libido. This is the mechanistic story the abstract presents: hormone loss leads to tissue and symptom changes that affect sexual function.
The review also stresses that hormones are only part of the picture. Chronic comorbidities, polypharmacy, and functional limitations can complicate or worsen sexual dysfunction in older adults. In men, gradual testosterone decline may impair libido and erectile function, so the topic applies to both sexes.
The stated aim is a clinically focused framework for evaluating and managing sexual dysfunction in geriatric practice. For clinicians, the takeaway is to treat sexual health as part of routine geriatric assessment, look at hormonal status alongside medications and other conditions, and avoid assuming these problems are simply inevitable.
There are important caveats. This summary rests on the abstract alone, so details of the evidence, specific therapies, their benefits and harms, and any recommendation strength are unknown. The abstract reports no new data, trial results, or effect sizes. It is a narrative review, and the quality of the evidence behind its framework cannot be judged from what was available. Readers should consult the full text before applying any specific treatment approach.
Key Findings
- Menopause is framed as a systemic endocrine transition driven by estrogen deficiency, not just a reproductive event.
- Falling estrogen and testosterone are linked to vaginal dryness, dyspareunia, and decreased libido in older women.
- Comorbidities, polypharmacy, and functional limitations can compound hormone-related sexual dysfunction in older adults.
- Gradual testosterone decline in men may impair libido and erectile function.
- The review offers a clinical framework for evaluating and managing sexual dysfunction in geriatric practice.
Methodology
This is a narrative review published in Clinics in Geriatric Medicine. The abstract does not describe a search strategy, number of studies, or evidence grading. No original data, sample sizes, or effect sizes are reported in the abstract.
Study Limitations
This summary is based on the abstract only, as the full text is not open access, so treatments, evidence quality, harms, and recommendations are not covered. The abstract reports no quantitative findings and gives no information on how evidence was selected or weighed. As a narrative review, it reflects author judgment rather than new data.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe:
